Sangamo prices follow-on offering of 3.1 million shares via Piper Jaffray

By Ronda Fears

Memphis, June 15 - Sangamo BioSciences, Inc. said Thursday that is has sold 3.1 million shares in a follow-on offering via bookrunner Piper Jaffray & Co.

There is a greenshoe for 465,000 shares available.

No other information on the deal was available.

Richmond, Calif.-based Sangamo engages in the research, development and commercialization of DNA binding proteins for the therapeutic regulation and modification of disease-related genes. Its technology platform is based on the engineering of a class of proteins known as zinc finger DNA-binding proteins.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.